Archives
PTEN mRNA: From Mechanism to Translation
2026-09-28
Restoring PTEN with modified mRNA offers a focused way to investigate PI3K/Akt signaling and resistance biology. This article connects the mechanistic rationale to nanoparticle-delivery evidence and practical decisions for translational cancer research.
Tau Ser356, Alzheimer’s Pathology, and NUAK Inhibition
2026-09-27
Taylor et al. report that tau phosphorylated at Ser356 increases with Alzheimer’s disease pathology, is found in neurofibrillary tangles, and localizes near synapses. Their ex vivo experiments show that the NUAK1/2 inhibitor WZ4003 lowers this tau species in human brain slices, while mouse slices show broader, culture-phase-dependent changes that include neuronal and synaptic proteins.
25-Hydroxycholesterol Reprograms Tumor Macrophages
2026-09-26
Xiao et al. identify a lysosomal 25-hydroxycholesterol–GPR155–mTORC1–AMPKα pathway that reinforces STAT6 activity and ARG1 production in immunosuppressive tumor-associated macrophages. The findings connect cholesterol metabolism to macrophage state and suggest CH25H as a target for improving antitumor immunity, including in combination with anti-PD-1 therapy.
MnTBAP Chloride: Reading Redox Rescue Carefully
2026-09-25
MnTBAP Chloride is a cell-permeable SOD mimetic used to probe superoxide-linked oxidative stress. This article explains how to interpret rescue experiments, connect behavioral and biochemical endpoints, and distinguish evidence for redox involvement from proof of a specific mechanism.
MHY1485 Workflows for mTOR and Autophagy Research
2026-09-25
Use MHY1485 to probe mTOR signaling and distinguish pathway activation from changes in autophagic flux. This workflow pairs practical compound handling with controls that help interpret LC3-II accumulation, cell responses, and tissue-specific findings.
Filipin III for Cholesterol Mapping in MASLD Models
2026-09-24
Use Filipin III to map accessible membrane cholesterol in liver-cell and tissue models, then relate those spatial patterns to cholesterol-homeostasis mechanisms implicated in MASLD. This practical guide covers fresh-reagent handling, interpretable controls, imaging limits, and ways to pair membrane mapping with orthogonal cholesterol measurements.
Recombinant Human IL-12: Assay Design Insights
2026-09-24
Explore how Recombinant Human IL-12 can support cytokine and immune-cell studies, and how to distinguish immune signaling from direct antibacterial effects. A 2025 MRSA study offers a practical lesson in selecting assays that match the mechanism being tested.
Hoechst 33258 for TNT and Tumor Cell Assays
2026-09-23
Use Hoechst 33258 to count and locate nuclei while investigating KRas transfer through tunneling nanotubes (TNTs)—without mistaking a DNA stain for a KRas or TNT marker. This practical guide combines live- and fixed-cell staining options with controls for imaging, cell-cycle analysis, and common sources of signal variability.
Antiarrhythmic Drugs and Cardiac KCa2 Channels
2026-09-23
The reference study used automated whole-cell patch clamp to test whether established antiarrhythmic drugs directly inhibit human KCa2.2 and KCa2.3 channels, an atrial-selective target under investigation for atrial fibrillation. Dronedarone was included in the screen but was not among the compounds showing measurable KCa2 inhibition, while dofetilide and propafenone acted only at concentrations well above their free therapeutic plasma levels.
Pulmonary CRISPR Editing with Lipid Nanoparticles
2026-09-22
The reference study developed biodegradable ionizable lipid nanoparticles that deliver mRNA and CRISPR-Cas9 components to mouse lung epithelium after intratracheal administration. Its high-throughput lipid discovery strategy produced pulmonary transfection substantially stronger than an MC3-based comparator and enabled editing in ciliated and club airway cells, while also identifying important barriers to clinical inhalation.
MnTBAP Chloride: Reading Redox Data in Context
2026-09-22
MnTBAP Chloride is a cell-permeable SOD mimetic for investigating mitochondrial superoxide, inflammation, and stress-related phenotypes. This guide shows how to connect redox, mitochondrial, cytokine, and behavioral readouts without overstating preclinical evidence.
Propidium Iodide in Immune-Cell Fate Assays
2026-09-21
Propidium iodide is a membrane-integrity reporter that adds critical interpretive resolution to immune-cell viability and apoptosis studies. This guide explains how to deploy the DNA intercalating dye in placenta–immune models while separating cell death measurements from mechanistic claims.
MTT Assay: From Metabolic Signal to Mechanism
2026-09-21
MTT, or 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide, is more than a viability dye. This guide explains how to use its metabolic signal to design and interpret mechanistic cancer-cell experiments, including the coculture strategy reported for activated mesenchymal stem cells and A549 cells.
HDAC Inhibitors Repress NUT Carcinoma Function
2026-09-20
This study developed a dCas9-based GFP reporter screen to identify small molecules that suppress NUT-driven transcription and uncovered structurally diverse HDAC inhibitors as potent repressors of NUT function. Panobinostat and IRBM6 reduced megadomain-associated oncogenic transcription, promoted differentiation, and restricted tumor growth in xenograft models, supporting chromatin acetylation as a therapeutic vulnerability in NUT carcinoma.
Icatibant in Viral Infections: Evidence and Limits
2026-09-19
This 2023 letter synthesizes case-based experience with icatibant in severe Puumala hantavirus infection and relates it to bradykinin-mediated vascular leakage in COVID-19. Its main contribution is a mechanistic and clinical rationale for early bradykinin receptor blockade, while its small, uncontrolled evidence base means efficacy remains unproven.